Enterprise Value
26.06M
Cash
3.121M
Avg Qtr Burn
-11.19M
Short % of Float
4.73%
Insider Ownership
0.65%
Institutional Own.
10.50%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
MultiStem (MASTERS-2) Details Ischemic stroke | Phase 3 Data readout | |
MultiStem (MACoVIA) Details COVID-19 Induced Acute Respiratory Distress Syndrome (ARDS) | Phase 2/3 Data readout | |
Phase 2 Data readout |